EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. Intra-Cellular Therapies, Inc. Transaction History

EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:

$1.73M
portfolio value

EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.00% -2.81K shares -556K $46.53 37.36K
Q2 2022 share Increase +3.74% 1.45K shares -77K $57.08 40.17K
Q1 2022 share Decrease -0.89% -346 shares 328K $61.19 38.72K
Q4 2021 share Increase 0.00% 39.07K shares 2.04M $52.13 39.07K